معرفی
Julia Klompenhouwer is a Researcher at the Department of Gastroenterology & Hepatology, Erasmus MC, Erasmus University Rotterdam. Her work focuses on benign liver tumors, portal hypertension, and hepatocellular adenoma. She collaborates extensively with national and international groups, contributing to clinical studies and case reports.
Research Interests: Dr. Klompenhouwer’s research explores the clinical course and management of benign liver tumors, including hepatocellular adenoma, focal nodular hyperplasia, and hepatic cysts. She investigates diagnostic strategies, treatment outcomes (e.g., embolization for portal hypertension), and gender-specific pathologies. Her work integrates pathology, genetics, and clinical practice to improve patient care.
Key Contributions: She led the nationwide BELIVER study (2022), a prospective cohort examining benign liver tumors in the Netherlands. Her case report (2024) highlights novel applications of portal embolization. Collaborations include the Dutch Benign Liver Tumor Group and European surveys on tumor management practices.
Grants/Advising: No specific grants or advisees are listed in the provided texts. Her research is likely funded through institutional grants related to liver diseases.
Labs/Teams: Active member of the Dutch Benign Liver Tumor Group and Erasmus MC’s Gastroenterology research team, focusing on clinical and translational studies in hepatology.
